A New Study: Acidic Aluminum Adjuvant In Vaccines Transfers to the Brain!
Danger signals from the CCL2 cytokine draw monocytes, which causes them to convert to macrophages before migrating to lymph nodes.
Dendritic cells (DCs) transfer antigens to a large network of distant dendritic cells, also known as antigen-presenting cells (APCs).
Alum injections are known to incite “significant changes linked to activation of the innate immune system in distant organs”.
First to the nearest lymph nodes.
Through the lymph system’s thoracic duct.
Through the thoracic duct into the bloodstream.
Through the blood to the spleen and possibly partially directly to the brain.
Dr. Exley was the conference administrator and has published a large number of studies on the topic, not to mention being involved in several of the studies and references of this conference.
Dr. Gherardi presented his latest work on macrophagic myofasciitis (MMF), a new vaccine-associated disease, indicating that the cytokine CCL2 is not simply a biomarker of MMF inflammation, but is also associated with its pathophysiology. He suggested that CCL2 should be investigated in relation to other autoimmune/inflammatory syndromes (ASIA).
Dr. Authier reported on a new non-invasive method to diagnose MMF, which has hitherto been diagnosable only via muscle biopsy. He also suggested that MMF is probably more prevalent than currently realized.
Slow CCL2-dependent translocation of biopersistent particles from muscle to brain , Biomed Central Medicine ; Zakir Khan, Christophe Combadière, François-Jérôme Authier, Valérie Itier, François Lux, Christopher Exley, Meriem Mahrouf-Yorgov, Xavier Decrouy, Philippe Moretto, Olivier Tillement, Romain K Gherardi, and Josette Cadusseau; doi:10.1186/1741-7015-11-99
Share on X (Opens in new window) X
Share on Pinterest (Opens in new window) Pinterest